SCHEMBL291818

SCHEMBL291818

[CH2]CCC#CCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL154493 0.92 PTPN7 (0.46)
SCHEMBL3856077 0.89 PTPN7 (0.50)
SCHEMBL4431565 0.89 PTPN7 (0.50)
SCHEMBL158129 0.89 PTPN7 (0.50)
SCHEMBL10948772 0.89 PTPN7 (0.50)
SCHEMBL7991151 0.89 PTPN7 (0.50)
SCHEMBL3858612 0.89 PTPN7 (0.50)
SCHEMBL10948997 0.89 PTPN7 (0.50)
SCHEMBL3863172 0.89 PTPN7 (0.50)
SCHEMBL1117071 0.88 TSHR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120232105-A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING OSTEOCLAST GROWTH NATIONAL DEFENSE MEDICAL CENTER (TW) 2012-09-13 US claimed
US-12037439-B2 Water-based polymer hydrogel system IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2024-07-16 US disclosed
EP-3191484-B1 PYRAZOLOPYRIDINE DERIVATIVES AND THEIR USE IN THERAPY HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) 2024-06-12 EP disclosed
WO-2024119098-A1 LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND FORMULATIONS PRIME MEDICINE, INC. (US) 2024-06-06 WO disclosed
EP-4351553-A1 NOVEL ANTI-FIBROTIC DRUGS Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH (DE) 2024-04-17 EP disclosed
CN-117642185-A Improved CD30 targeting antibody drug conjugates and uses thereof 路德维希-马克西米利安慕尼黑大学 2024-03-01 CN disclosed
US-20240018281-A1 WATER-BASED POLYMER HYDROGEL SYSTEM IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2024-01-18 US disclosed
US-20240018282-A1 METHOD FOR MAKING AN AQUEOUS HYDROGEL COMPOSITION IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2024-01-18 US disclosed
US-11814459-B2 Aqueous solution method for forming a hydrogel composition IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-11-14 US disclosed
US-20230348453-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2023-11-02 US disclosed
US-4996201-A Alzheimer's disease WARNER-LAMBERT CO. (US) 1991-02-26 US disclosed
EP-0411616-A1 4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents WARNER-LAMBERT COMPANY (US) 1991-02-06 EP disclosed
EP-0411615-A1 4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents WARNER-LAMBERT COMPANY (US) 1991-02-06 EP disclosed
US-4988688-A Cognitive activators WARNER-LAMBERT COMPANY (US) 1991-01-29 US disclosed
EP-0232776-B1 2,5,6,7-TETRANOR-4,8-INTER-M-PHENYLENE PGI2 DERIVATIVES TORAY INDUSTRIES, INC. (JP) 1990-10-24 EP disclosed
EP-0389162-A1 2,5,6,7-Tetranor-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1990-09-26 EP disclosed
US-4880939-A ANTISECRETORY AGENTS, HYPOTENSIVES, ANTICOAGULANTS TORAY INDUSTRIES (JP) 1989-11-14 US disclosed
US-4775692-A ANTILIPEMIC, ANTICOAGULANT, HYPOTENSIVE, ANTISECRETORY AND ANTIULCER AGENT TORAY INDUSTRIES, INC. (JP) 1988-10-04 US disclosed
EP-0274064-A2 2,5,6,7-Tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1988-07-13 EP disclosed
EP-0232776-A2 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1987-08-19 EP disclosed